Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Florian Walter

Obstetrics & Gynecology Phoenix, AZ Doctor of Osteopathy

NPI 1407835192 CMS profile 245893

10240 W Indian School Rd, Building 2 Ste 140, Phoenix, AZ 85037

Open in the dashboard

General payments

$15,476

146 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Florian Walter of Phoenix, AZ is reported in the CMS Open Payments database as having received $15,476 across 146 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $678 31
2024 General $562 23
2023 General $13,143 37
2022 General $538 31
2021 General $87 5
2020 General $33 2
2019 General $436 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Florian Walter
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Florian Walter were reported at $678. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Florian Walter Obstetrics & Gynecology median Middle half National median
2019 $436 $172 $62–$391 $163
2020 $33 $94 $36–$222 $114
2021 $87 $136 $42–$369 $132
2022 $538 $160 $50–$433 $149
2023 $13,143 $169 $56–$423 $160
2024 $562 $152 $50–$371 $164
2025 $678 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $12,557 8 payments
  2. AbbVie, Inc. $468 15 payments
  3. Astellas Pharma US Inc $455 19 payments
  4. Sumitomo Pharma America, Inc. $368 20 payments
  5. Myovant Sciences Inc. $299 20 payments
  6. Organon LLC $167 9 payments
  7. Hologic, LLC $164 8 payments
  8. Bayer HealthCare Pharmaceuticals Inc. $100 5 payments
  9. CooperSurgical, Inc. $89 5 payments
  10. Medtronic, Inc. $81 3 payments
  11. Other $728 34 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $12,127 7 payments
  2. Food and Beverage $3,307 137 payments
  3. Gift $23 1 payment
  4. Travel and Lodging $19 1 payment
Products named General payments · program years 2019–2025
  1. DAVINCI XI $12,000 4 payments
  2. MYFEMBREE $581 36 payments
  3. Da Vinci Surgical System $557 4 payments
  4. Veozah $362 18 payments
  5. LO LOESTRIN FE $139 7 payments
  6. NEXPLANON $131 7 payments
  7. Orilissa Endocrinology $127 3 payments
  8. HUMIRA $110 1 payment
  9. ORILISSA Womens Health $107 5 payments
  10. ACESSA PROVU SYSTEM $96 5 payments
  11. Other $1,862 92 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

57

Median for Obstetrics & Gynecology: 65

Drug cost

$1,977

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

0%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 33 $1,639
Medroxyprogesterone Acetate Generic 24 $338

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$9,902

Medicare's payments for the services billed

Medicare patients

51

Average age 71

Services billed

134

51 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 55%
Arthritis 55%
Depression 27%
Chronic kidney disease 25%
Cancer 24%
Osteoporosis 24%
Ischemic heart disease 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Veozah
  • Astellas Pharma US Inc $92
$92 — —
MYFEMBREE
  • Sumitomo Pharma America, Inc. $65
  • PFIZER INC. $12
$77 — —
PREMARIN
  • PFIZER INC. $12
$12 — —
ABRYSVO
  • PFIZER INC. $8
$8 — —
Mirena
  • Bayer HealthCare Pharmaceuticals Inc. $7
$7 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record